Siga Technologies (SIGA) Operating Income Growth (3y) (2013 - 2025)
Siga Technologies (SIGA) Operating Income Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.84 Bn | 32.10 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.69 Bn | 23.63 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.12 Bn | 20.97 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.24 Bn | 18.44 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.22 Bn | 785.00 Mn | 40.17% |
| 10 | Siga Technologies | 223.77 Mn | 68.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.81% |
| Jun 30, 2025 | 145.94% |
| Mar 31, 2025 | -16.16% |
| Dec 31, 2024 | -15.32% |
| Sep 30, 2024 | 29.75% |
| Jun 30, 2024 | 893.25% |
| Mar 31, 2024 | 97.19% |
| Dec 31, 2023 | 50.67% |
| Sep 30, 2023 | -26.82% |
| Jun 30, 2023 | -29.29% |
| Mar 31, 2023 | 19.21% |
| Dec 31, 2022 | 19.58% |
| Sep 30, 2022 | 301.87% |
| Jun 30, 2022 | 56.06% |
| Mar 31, 2022 | -38.49% |
| Dec 31, 2021 | 166.69% |
| Sep 30, 2021 | -26.16% |
| Jun 30, 2021 | 26.00% |
| Mar 31, 2021 | 24.02% |
| Dec 31, 2020 | 95.77% |